1005 BiXAb® MAIT Engagers: solving the problems of classical T-cell engagers in the treatment of solid tumors

• Claire Germain,
• Matthias Peipp,
• Simon E Plyte,
• Marie Fraudeau,
• Dorothee Winterberg,
• Camille Rousseau,
• Gaetano Sodaro,
• Maxime Audin,
• Alexandre Ivagnes,
• Hans Heinrich Oberg,
• Pierre Emmanuel Gerard,
• Daniela Wesch,
• Julie Prigent

Affiliations

Claire Germain

Centre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, France

Matthias Peipp

3University Hospital Schleswig-Holstein, Campus Kiel, and Christian-Albrechts-University, Kiel, Germany

Simon E Plyte

1Biomunex Pharmaceuticals, Paris, France

Marie Fraudeau

1Biomunex Pharmaceuticals, Paris, France

Dorothee Winterberg

2University Hospital Schleswig-Holstein, Kiel, Germany

Camille Rousseau

1Biomunex Pharmaceuticals, Paris, France

Gaetano Sodaro

1Biomunex Pharmaceuticals, Paris, France

Maxime Audin

1Biomunex Pharmaceuticals, Paris, France

Alexandre Ivagnes

1Biomunex Pharmaceuticals, Paris, France

Hans Heinrich Oberg

2University Hospital Schleswig-Holstein, Kiel, Germany

Pierre Emmanuel Gerard

1Biomunex Pharmaceuticals, Paris, France

Daniela Wesch

2University Hospital Schleswig-Holstein, Kiel, Germany

Julie Prigent

1Biomunex Pharmaceuticals, Paris, France